Quick Dispatch:
Your tirzepatide heart failure trial An Observational Study of Cardiovascular Outcomes of Tirzepatide vs Glucagon-Like Peptide-1 Receptor Agonists orders ship within 1-2 business days.
Delivery Options:
Order Tracking:
You'll receive a tracking link by email once your tirzepatide heart failure trial An Observational Study of Cardiovascular Outcomes of Tirzepatide vs Glucagon-Like Peptide-1 Receptor Agonists ships.
Need Help?
Questions about tirzepatide heart failure trial An Observational Study of Cardiovascular Outcomes of Tirzepatide vs Glucagon-Like Peptide-1 Receptor Agonists, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for tirzepatide heart failure trial An Observational Study of Cardiovascular Outcomes of Tirzepatide vs Glucagon-Like Peptide-1 Receptor Agonists in your area.
Effects of Tirzepatide on the Clinical Trajectory of Patients With Heart Failure, Preserved Ejection Fraction, and Obesity
26.73
In the SUMMIT trial, researchers examined cardiovascular outcomes of treatment with tirzepatide in patients with heart failure with preserved ejection fraction and obesity. Full trial results and Plain Language Summary: https://t.co/8joe2mst3e
21.15
Lilly's Tirzepatide Reduced Heart Failure and Obesity Symptoms in Phase 3 Trial
27.79
UC Irvine researchers project cardiac benefits from weight-loss medication tirzepatide
29.67
At #ACC25, Dr. Milton Packer and colleagues present a new secondary analysis from the SUMMIT trial evaluating the effect of tirzepatide in patients with obesity, #HFpEF, and CKD. The trial demonstrated that #
28.08
Effects of Tirzepatide on the Clinical Trajectory of Patients With Heart Failure, Preserved Ejection Fraction, and Obesity
25.68
Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity: @NEJM 🥸The SUMMIT trial
25.19
,aspect=ignore)